Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
NCT ID:
NCT02488369
Eligibility Criteria:
Inclusion Criteria:
1. All cases of NHL corresponding to one of the following histologies:
* Burkitt and Burkitt-like (LB)
* Large cell B-cell lymphoma (LBGC)
* Primary mediastinal B cell lymphoma (LBPM)
* Lymphoblastic lymphoma (LL)
* Anaplastic large cell lymphoma (ALCL)
2. Age \> 2 years and \< 21 years
3. Treated in a SFCE protocol
4. Treated in a center with the possibility of organizing a PET / CT at the time of remission assessment
5. Affiliation to a social security system
6. Possible follow-up for at least 2 years
7. written informed consent signed by the parents or parental authority or the patient himself if he is over 18 years
Exclusion Criteria:
1. relapsing patients
2. Patients with absolute cons-indications to the achievement of a PET scan: pregnancy, incontinence, poorly controlled diabetes or blood glucose\> 10 mmol/l, alterations of superior functions or claustrophobia, making the test impossible.
3. pre-existing or evolving infectious inflammatory disease making PET / CT difficult to interpret
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
21 Years
Study:
NCT02488369
Study Brief:
Protocol Section:
NCT02488369